Biotech Breakthroughs

Results

56

1 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

56 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	MDGL	US$537.65	-2.3%	75.3%	US$12.6b	US$679.64	10.9	59.7%	n/a	Pharmaceuticals & Biotech
	SNDX	US$22.05	-6.3%	115.8%	US$2.0b	US$39.45	9.0	68.1%	n/a	Pharmaceuticals & Biotech
	ANAB	US$52.61	-5.8%	94.9%	US$1.6b	US$87.09	6.7	48.1%	42.8%	Pharmaceuticals & Biotech
	MRKR	US$1.24	-12.1%	-22.5%	US$21.2m	US$7.87	5.8	69.0%	n/a	Pharmaceuticals & Biotech
	ARDX	US$5.08	-4.2%	15.7%	US$1.3b	US$16.30	2.9	56.0%	n/a	Pharmaceuticals & Biotech
	RNXT	US$0.87	0.7%	-31.9%	US$39.6m	US$7.03	26.2	73.0%	n/a	Pharmaceuticals & Biotech
	FRMM	US$5.70	-4.7%	-75.1%	US$81.0m	US$9.50	8.0	127.7%	n/a	Pharmaceuticals & Biotech
	ACHV	US$6.31	-0.3%	131.1%	US$667.3m	US$13.80	60.7	64.3%	n/a	Pharmaceuticals & Biotech
	ALDX	US$1.70	-11.5%	-69.3%	US$105.6m	US$7.17	2.4	66.9%	n/a	Pharmaceuticals & Biotech
	CAPR	US$18.91	-7.1%	177.3%	US$1.1b	US$53.60	3.9	64.2%	n/a	Pharmaceuticals & Biotech
	TNYA	US$0.79	-6.4%	-9.2%	US$178.9m	US$4.00	760.9	60.9%	n/a	Pharmaceuticals & Biotech
	NTLA	US$11.13	-14.6%	-21.8%	US$1.6b	US$26.17	23.5	67.9%	n/a	Pharmaceuticals & Biotech
	LCTX	US$1.11	-5.1%	-3.5%	US$276.7m	US$5.50	18.7	72.2%	n/a	Pharmaceuticals & Biotech
	CTOR	US$0.57	-16.8%	-68.5%	US$53.0m	US$4.00	9.5	59.9%	n/a	Pharmaceuticals & Biotech
	LGVN	US$0.63	-1.4%	-64.0%	US$19.3m	US$7.15	16.3	55.5%	n/a	Pharmaceuticals & Biotech
	VRDN	US$19.17	0.6%	6.8%	US$2.1b	US$36.13	29.8	60.9%	n/a	Pharmaceuticals & Biotech
	ARQT	US$27.90	0.4%	87.1%	US$3.5b	US$34.63	8.4	48.1%	n/a	Pharmaceuticals & Biotech
	CGON	US$69.31	-5.1%	163.3%	US$6.3b	US$90.69	1205.5	61.1%	n/a	Pharmaceuticals & Biotech
	ACIU	US$2.27	4.1%	-6.6%	US$225.2m	US$8.56	49.5	47.1%	n/a	Pharmaceuticals & Biotech
	HUMA	US$0.64	-5.4%	-76.4%	US$180.9m	US$2.05	86.2	60.9%	n/a	Pharmaceuticals & Biotech
	NAMS	US$31.70	-0.9%	32.2%	US$3.8b	US$50.24	164.2	64.4%	n/a	Pharmaceuticals & Biotech
	VERA	US$36.06	-15.2%	59.3%	US$2.7b	US$81.79	5.2	63.8%	n/a	Pharmaceuticals & Biotech
	LRMR	US$4.02	5.5%	6.9%	US$410.2m	US$14.40	2.7	52.5%	n/a	Pharmaceuticals & Biotech
	MNOV	US$1.33	-5.0%	5.6%	US$65.5m	US$9.00	109.7	66.7%	n/a	Pharmaceuticals & Biotech

Page 1 of 2